| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9163705 | Chest | 2005 | 7 Pages |
Abstract
There was significant improvement in Emax to inhaled albuterol as the COPD exacerbation resolved. There was no significant difference in outcomes including length of hospital stay or recovery of lung function between patients treated with regular 2.5 mg vs 5 mg of nebulized albuterol during an AECOPD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nair MBBS, Thomas MBBS, Pearson DPhil, DM, Henry MSc, MD,